These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24586292)

  • 1. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.
    Bruzzese E; Callegari ML; Raia V; Viscovo S; Scotto R; Ferrari S; Morelli L; Buccigrossi V; Lo Vecchio A; Ruberto E; Guarino A
    PLoS One; 2014; 9(2):e87796. PubMed ID: 24586292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis.
    Ray KJ; Santee C; McCauley K; Panzer AR; Lynch SV
    BMC Pulm Med; 2022 Jul; 22(1):287. PubMed ID: 35902830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis.
    de Freitas MB; Moreira EAM; Tomio C; Moreno YMF; Daltoe FP; Barbosa E; Ludwig Neto N; Buccigrossi V; Guarino A
    PLoS One; 2018; 13(6):e0198457. PubMed ID: 29933382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
    del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
    J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn's-Like Microbiota Disturbances.
    Enaud R; Hooks KB; Barre A; Barnetche T; Hubert C; Massot M; Bazin T; Clouzeau H; Bui S; Fayon M; Berger P; Lehours P; Bébéar C; Nikolski M; Lamireau T; Delhaes L; Schaeverbeke T
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31083321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.
    Bruzzese E; Raia V; Ruberto E; Scotto R; Giannattasio A; Bruzzese D; Cavicchi MC; Francalanci M; Colombo C; Faelli N; Daccò V; Magazzù G; Costa S; Lucidi V; Majo F; Guarino A
    J Cyst Fibros; 2018 May; 17(3):375-382. PubMed ID: 29128317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study.
    Bruzzese E; Raia V; Spagnuolo MI; Volpicelli M; De Marco G; Maiuri L; Guarino A
    Clin Nutr; 2007 Jun; 26(3):322-8. PubMed ID: 17360077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
    Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
    PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.
    Vernocchi P; Del Chierico F; Quagliariello A; Ercolini D; Lucidi V; Putignani L
    Nutrients; 2017 Dec; 9(12):. PubMed ID: 29232848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.
    Bruzzese E; Raia V; Gaudiello G; Polito G; Buccigrossi V; Formicola V; Guarino A
    Aliment Pharmacol Ther; 2004 Oct; 20(7):813-9. PubMed ID: 15379842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commercial microbiota test revealed differences in the composition of intestinal microorganisms between children with autism spectrum disorders and neurotypical peers.
    Jendraszak M; Gałęcka M; Kotwicka M; Regdos A; Pazgrat-Patan M; Andrusiewicz M
    Sci Rep; 2021 Dec; 11(1):24274. PubMed ID: 34931007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota.
    Duytschaever G; Huys G; Bekaert M; Boulanger L; De Boeck K; Vandamme P
    J Cyst Fibros; 2013 May; 12(3):206-15. PubMed ID: 23151540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining the role of a probiotic in the restoration of intestinal microbial balance by molecular and cultural techniques.
    Shoaib A; Dachang W; Xin Y
    Genet Mol Res; 2015 Feb; 14(1):1526-37. PubMed ID: 25730092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
    Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
    PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic supplementation in children with cystic fibrosis-a systematic review.
    Ananthan A; Balasubramanian H; Rao S; Patole S
    Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus rhamnosus GG Intake Modifies Preschool Children's Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use.
    Korpela K; Salonen A; Virta LJ; Kumpu M; Kekkonen RA; de Vos WM
    PLoS One; 2016; 11(4):e0154012. PubMed ID: 27111772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents.
    Larsen N; Vogensen FK; Gøbel RJ; Michaelsen KF; Forssten SD; Lahtinen SJ; Jakobsen M
    Clin Nutr; 2013 Dec; 32(6):935-40. PubMed ID: 23510724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The altered gut microbiota in adults with cystic fibrosis.
    Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
    BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.